nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—Azathioprine—Crohn's disease	0.588	0.937	CbGbCtD
Ethacrynic acid—ALB—Crohn's disease	0.318	1	CbGaD
Ethacrynic acid—ALB—Prednisone—Crohn's disease	0.0392	0.0625	CbGbCtD
Ethacrynic acid—GSTA2—gall bladder—Crohn's disease	0.00388	0.166	CbGeAlD
Ethacrynic acid—ALB—gall bladder—Crohn's disease	0.00214	0.0912	CbGeAlD
Ethacrynic acid—ATP1A1—gall bladder—Crohn's disease	0.00206	0.0878	CbGeAlD
Ethacrynic acid—GSTA2—epithelium—Crohn's disease	0.00201	0.0858	CbGeAlD
Ethacrynic acid—ATP1A1—mouth—Crohn's disease	0.00183	0.0781	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—Crohn's disease	0.00183	0.0781	CbGeAlD
Ethacrynic acid—Pancreatitis acute—Mesalazine—Crohn's disease	0.00166	0.0613	CcSEcCtD
Ethacrynic acid—GSTA2—lymphoid tissue—Crohn's disease	0.00155	0.0661	CbGeAlD
Ethacrynic acid—GSTA2—digestive system—Crohn's disease	0.00153	0.0653	CbGeAlD
Ethacrynic acid—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00153	0.0562	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00144	0.0531	CcSEcCtD
Ethacrynic acid—ATP1A1—epithelium—Crohn's disease	0.00106	0.0454	CbGeAlD
Ethacrynic acid—ATP1A1—smooth muscle tissue—Crohn's disease	0.00102	0.0438	CbGeAlD
Ethacrynic acid—ATP1A1—skin of body—Crohn's disease	0.00101	0.0432	CbGeAlD
Ethacrynic acid—ATP1A1—mammalian vulva—Crohn's disease	0.000923	0.0394	CbGeAlD
Ethacrynic acid—Pancreatitis acute—Prednisone—Crohn's disease	0.00088	0.0324	CcSEcCtD
Ethacrynic acid—Gout—Mesalazine—Crohn's disease	0.000823	0.0303	CcSEcCtD
Ethacrynic acid—ATP1A1—lymphoid tissue—Crohn's disease	0.000819	0.035	CbGeAlD
Ethacrynic acid—ATP1A1—digestive system—Crohn's disease	0.000809	0.0346	CbGeAlD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—SOX11—Crohn's disease	0.000678	0.155	CbGpPWpGaD
Ethacrynic acid—Deafness—Mesalazine—Crohn's disease	0.000623	0.023	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000558	0.0205	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Mesalazine—Crohn's disease	0.000515	0.019	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Azathioprine—Crohn's disease	0.000507	0.0187	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000495	0.0182	CcSEcCtD
Ethacrynic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000493	0.113	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000493	0.113	CbGpPWpGaD
Ethacrynic acid—Dysphagia—Mesalazine—Crohn's disease	0.000482	0.0177	CcSEcCtD
Ethacrynic acid—Anorexia—Mercaptopurine—Crohn's disease	0.000481	0.0177	CcSEcCtD
Ethacrynic acid—ALB—lymph node—Crohn's disease	0.00048	0.0205	CbGeAlD
Ethacrynic acid—ATP1A1—lymph node—Crohn's disease	0.000462	0.0197	CbGeAlD
Ethacrynic acid—Abdominal discomfort—Mesalazine—Crohn's disease	0.000462	0.017	CcSEcCtD
Ethacrynic acid—Neutropenia—Mesalazine—Crohn's disease	0.000451	0.0166	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Azathioprine—Crohn's disease	0.00044	0.0162	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mercaptopurine—Crohn's disease	0.000439	0.0162	CcSEcCtD
Ethacrynic acid—Jaundice—Mesalazine—Crohn's disease	0.000419	0.0154	CcSEcCtD
Ethacrynic acid—Haematuria—Mesalazine—Crohn's disease	0.00041	0.0151	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Mesalazine—Crohn's disease	0.000401	0.0148	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mercaptopurine—Crohn's disease	0.000399	0.0147	CcSEcCtD
Ethacrynic acid—Chills—Azathioprine—Crohn's disease	0.00038	0.014	CcSEcCtD
Ethacrynic acid—Tinnitus—Mesalazine—Crohn's disease	0.00036	0.0132	CcSEcCtD
Ethacrynic acid—Chills—Mesalazine—Crohn's disease	0.000346	0.0127	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mercaptopurine—Crohn's disease	0.000346	0.0127	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Azathioprine—Crohn's disease	0.000342	0.0126	CcSEcCtD
Ethacrynic acid—Malaise—Azathioprine—Crohn's disease	0.000333	0.0122	CcSEcCtD
Ethacrynic acid—Vomiting—Mercaptopurine—Crohn's disease	0.000321	0.0118	CcSEcCtD
Ethacrynic acid—Rash—Mercaptopurine—Crohn's disease	0.000318	0.0117	CcSEcCtD
Ethacrynic acid—Dermatitis—Mercaptopurine—Crohn's disease	0.000318	0.0117	CcSEcCtD
Ethacrynic acid—Vision blurred—Mesalazine—Crohn's disease	0.000317	0.0117	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Mesalazine—Crohn's disease	0.000312	0.0115	CcSEcCtD
Ethacrynic acid—Discomfort—Azathioprine—Crohn's disease	0.00031	0.0114	CcSEcCtD
Ethacrynic acid—Malaise—Mesalazine—Crohn's disease	0.000303	0.0112	CcSEcCtD
Ethacrynic acid—Vertigo—Mesalazine—Crohn's disease	0.000302	0.0111	CcSEcCtD
Ethacrynic acid—Nausea—Mercaptopurine—Crohn's disease	0.0003	0.011	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000295	0.0109	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Azathioprine—Crohn's disease	0.000295	0.0108	CcSEcCtD
Ethacrynic acid—Anxiety—Mesalazine—Crohn's disease	0.000285	0.0105	CcSEcCtD
Ethacrynic acid—Discomfort—Mesalazine—Crohn's disease	0.000283	0.0104	CcSEcCtD
Ethacrynic acid—Confusional state—Mesalazine—Crohn's disease	0.000276	0.0102	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mesalazine—Crohn's disease	0.000268	0.00988	CcSEcCtD
Ethacrynic acid—Anorexia—Mesalazine—Crohn's disease	0.000261	0.00962	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Azathioprine—Crohn's disease	0.000248	0.00913	CcSEcCtD
Ethacrynic acid—Neutropenia—Prednisone—Crohn's disease	0.000238	0.00878	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mesalazine—Crohn's disease	0.000238	0.00877	CcSEcCtD
Ethacrynic acid—Body temperature increased—Azathioprine—Crohn's disease	0.000238	0.00876	CcSEcCtD
Ethacrynic acid—Fatigue—Mesalazine—Crohn's disease	0.000236	0.0087	CcSEcCtD
Ethacrynic acid—Pain—Mesalazine—Crohn's disease	0.000234	0.00863	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Prednisone—Crohn's disease	0.00023	0.00847	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mesalazine—Crohn's disease	0.000226	0.00832	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mesalazine—Crohn's disease	0.000217	0.00798	CcSEcCtD
Ethacrynic acid—Diarrhoea—Azathioprine—Crohn's disease	0.000206	0.00758	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000204	0.0466	CbGpPWpGaD
Ethacrynic acid—Asthenia—Mesalazine—Crohn's disease	0.000197	0.00724	CcSEcCtD
Ethacrynic acid—Vomiting—Azathioprine—Crohn's disease	0.000191	0.00704	CcSEcCtD
Ethacrynic acid—Rash—Azathioprine—Crohn's disease	0.00019	0.00699	CcSEcCtD
Ethacrynic acid—Dermatitis—Azathioprine—Crohn's disease	0.00019	0.00698	CcSEcCtD
Ethacrynic acid—Headache—Azathioprine—Crohn's disease	0.000189	0.00694	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mesalazine—Crohn's disease	0.000188	0.00691	CcSEcCtD
Ethacrynic acid—Nausea—Azathioprine—Crohn's disease	0.000179	0.00658	CcSEcCtD
Ethacrynic acid—Vomiting—Mesalazine—Crohn's disease	0.000174	0.00642	CcSEcCtD
Ethacrynic acid—Rash—Mesalazine—Crohn's disease	0.000173	0.00636	CcSEcCtD
Ethacrynic acid—Dermatitis—Mesalazine—Crohn's disease	0.000173	0.00636	CcSEcCtD
Ethacrynic acid—Headache—Mesalazine—Crohn's disease	0.000172	0.00632	CcSEcCtD
Ethacrynic acid—Vision blurred—Prednisone—Crohn's disease	0.000167	0.00617	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisone—Crohn's disease	0.000165	0.00607	CcSEcCtD
Ethacrynic acid—Nausea—Mesalazine—Crohn's disease	0.000163	0.00599	CcSEcCtD
Ethacrynic acid—Malaise—Prednisone—Crohn's disease	0.00016	0.0059	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisone—Crohn's disease	0.00016	0.00588	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisone—Crohn's disease	0.000154	0.00567	CcSEcCtD
Ethacrynic acid—Anxiety—Prednisone—Crohn's disease	0.000151	0.00555	CcSEcCtD
Ethacrynic acid—Discomfort—Prednisone—Crohn's disease	0.000149	0.0055	CcSEcCtD
Ethacrynic acid—Anorexia—Prednisone—Crohn's disease	0.000138	0.00509	CcSEcCtD
Ethacrynic acid—Decreased appetite—Prednisone—Crohn's disease	0.000126	0.00464	CcSEcCtD
Ethacrynic acid—Fatigue—Prednisone—Crohn's disease	0.000125	0.0046	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisone—Crohn's disease	0.00012	0.0044	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000118	0.027	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000118	0.027	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Prednisone—Crohn's disease	0.000115	0.00422	CcSEcCtD
Ethacrynic acid—Asthenia—Prednisone—Crohn's disease	0.000104	0.00383	CcSEcCtD
Ethacrynic acid—Diarrhoea—Prednisone—Crohn's disease	9.92e-05	0.00365	CcSEcCtD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	9.87e-05	0.0225	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	9.87e-05	0.0225	CbGpPWpGaD
Ethacrynic acid—Vomiting—Prednisone—Crohn's disease	9.22e-05	0.00339	CcSEcCtD
Ethacrynic acid—Rash—Prednisone—Crohn's disease	9.14e-05	0.00337	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisone—Crohn's disease	9.14e-05	0.00336	CcSEcCtD
Ethacrynic acid—Headache—Prednisone—Crohn's disease	9.09e-05	0.00335	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	8.77e-05	0.02	CbGpPWpGaD
Ethacrynic acid—Nausea—Prednisone—Crohn's disease	8.61e-05	0.00317	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	8.32e-05	0.019	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	7.82e-05	0.0179	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	7.35e-05	0.0168	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	6.15e-05	0.014	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6e-05	0.0137	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6e-05	0.0137	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.68e-05	0.013	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.45e-05	0.0124	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.45e-05	0.0124	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—GPX4—Crohn's disease	5.09e-05	0.0116	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	4.77e-05	0.0109	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	4.48e-05	0.0102	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	4.48e-05	0.0102	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—F5—Crohn's disease	4.42e-05	0.0101	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.23e-05	0.00966	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	4.21e-05	0.00962	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	4.05e-05	0.00924	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—MPO—Crohn's disease	3.88e-05	0.00887	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.84e-05	0.00877	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.74e-05	0.00854	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.39e-05	0.00775	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.16e-05	0.00722	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	3.09e-05	0.00705	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PLA2G4F—Crohn's disease	3e-05	0.00686	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.79e-05	0.00638	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.65e-05	0.00605	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTMR3—Crohn's disease	2.55e-05	0.00583	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	2.51e-05	0.00573	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.33e-05	0.00533	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.33e-05	0.00533	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	2.31e-05	0.00527	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.28e-05	0.00521	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.28e-05	0.00521	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—CRP—Crohn's disease	2.04e-05	0.00467	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—FADS1—Crohn's disease	1.99e-05	0.00454	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	1.96e-05	0.00448	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—ICAM1—Crohn's disease	1.88e-05	0.00429	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GPX4—Crohn's disease	1.86e-05	0.00425	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GCKR—Crohn's disease	1.8e-05	0.00411	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	1.76e-05	0.00401	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.64e-05	0.00375	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	1.62e-05	0.00371	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.61e-05	0.00367	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	1.57e-05	0.00358	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.49e-05	0.00341	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.47e-05	0.00335	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.45e-05	0.00332	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IFNG—Crohn's disease	1.43e-05	0.00326	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.42e-05	0.00324	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.35e-05	0.00307	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL1B—Crohn's disease	1.27e-05	0.00291	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.25e-05	0.00285	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.22e-05	0.00279	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.18e-05	0.00271	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.18e-05	0.00271	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	1.18e-05	0.00269	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	1.14e-05	0.0026	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	1.14e-05	0.0026	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	1.13e-05	0.00259	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.09e-05	0.00249	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.01e-05	0.00231	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—F5—Crohn's disease	1.01e-05	0.00231	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.01e-05	0.0023	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.71e-06	0.00222	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—Crohn's disease	9.25e-06	0.00211	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	9.17e-06	0.00209	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.09e-06	0.00208	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.35e-06	0.00191	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	8.23e-06	0.00188	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—Crohn's disease	7.46e-06	0.0017	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.38e-06	0.00169	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	7.35e-06	0.00168	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PLA2G4F—Crohn's disease	6.53e-06	0.00149	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGA4—Crohn's disease	6.21e-06	0.00142	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL3—Crohn's disease	6.06e-06	0.00138	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	5.93e-06	0.00135	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RASGRP1—Crohn's disease	5.86e-06	0.00134	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—Crohn's disease	5.72e-06	0.00131	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTMR3—Crohn's disease	5.55e-06	0.00127	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	5.53e-06	0.00126	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	5.11e-06	0.00117	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—Crohn's disease	5.01e-06	0.00114	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FADS1—Crohn's disease	4.32e-06	0.000988	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2RA—Crohn's disease	4.24e-06	0.00097	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX4—Crohn's disease	4.05e-06	0.000925	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCKR—Crohn's disease	3.91e-06	0.000893	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—JAK2—Crohn's disease	2.85e-06	0.000652	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.44e-06	0.000558	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—Crohn's disease	1.09e-06	0.000249	CbGpPWpGaD
